<!DOCTYPE html>
<html lang="en-us">
<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 3.1.1">
  <meta name="generator" content="Hugo 0.51" />
  <meta name="author" content="Markus List">

  
  
  
  
    
  
  <meta name="description" content="*Background*&lt;br/&gt;Glioblastoma multiforme is the most frequent malignant brain tumor in adults being marked with a very poor prognosis. Therapy concept implies concomitant radio-chemotherapy and facultative implantation of carmustine-eluted wafer. Current literature suggests microRNA 26a expression in glioblastoma to interact with alkylating chemotherapy. Subsequently, the aim of this study was to investigate the correlation of miRNA-26a expression and carmustine wafer implantation and its potential usefulness as a predictive marker for therapy response.&lt;br/&gt;&lt;br/&gt;*Methods*&lt;br/&gt;In total, 229 patients with glioblastoma multiforme were included into the final analysis. Of them, 80 cases were recruited from the Saarland University Medical Center for a retrospective matched-pair analysis stratified after therapy regime: One group (carmustine wafer group; n=40) received concomitant radio-chemotherapy with carmustine wafer implantation. The other group (control group; n=40) only received concomitant radio-chemotherapy. The results were confirmed by comparing them with an independent dataset of 149 patients from the TCGA database. All tumor specimens were evaluated for miRNA-26a expression, MGMT promoter methylation, and IDH1 R132H mutation status, and the results were correlated with the clinical data.&lt;br/&gt;&lt;br/&gt;*Results*&lt;br/&gt;Twenty-three patients in the carmustine wafer group showed low expression of miRNA-26a, while 17 patients showed a high expression. In the control group, 28 patients showed low expression, while 12 patients showed a high expression. The patients with high miRNA-26a expression in the carmustine wafer group were characterized by a significantly longer overall (hazard ratio [HR] 2.750 [95% CI 1.352–5.593]; p=0.004) and progression-free survival (HR 3.091 [95% CI 1.436–6.657]; p=0.003) than patients with low miRNA-26a expression. The 17 patients in the carmustine wafer group with high miRNA-26a expression showed a significantly longer progression-free survival (p=0.013) and overall survival (p=0.007) compared with the control group. There were no such correlations identified within the control group. TCGA datasets supported these findings.&lt;br/&gt;&lt;br/&gt;*Conclusions*&lt;br/&gt;MiRNA-26a expression turned out to be a promising predictor of therapy response and clinical outcome in glioblastoma patients treated with carmustine wafer implantation. For evaluation of the role of miRNA-26a in a combined therapy setting, further studies are needed in order to translate general findings to the patient’s individual situation.">

  
  <link rel="alternate" hreflang="en-us" href="https://biomedical-big-data.de/publication/sippl-2019/">

  


  

  

  

  
  
  
  <meta name="theme-color" content="hsl(36, 90%, 58%)">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/css/bootstrap.min.css" integrity="sha256-eSi1q2PG6J7g7ib17yAaWMcrr5GrtohYChqibrV7PBE=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.4.1/css/all.css" integrity="sha384-5sAR7xN1Nv6T6+dT2mhtzEpVJvfS3NScPQTrOxhwjIuvcA67KV2R5Jz6kr4abQsz" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/dracula.min.css" crossorigin="anonymous">
        
      
    

    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.css" integrity="sha512-M2wvCLH6DSRazYeZRIm1JnYyh22purTM+FDB5CsyxtQJYeKq83arPe5wgbNmcFXGqiSH2XR8dT/fJISVA1r/zQ==" crossorigin="anonymous">
    

    

  

  
  
  <link rel="stylesheet" href="/css/roboto.css">
  

  <link rel="stylesheet" href="/styles.css">
  

  
  
  

  
  <link rel="alternate" href="https://biomedical-big-data.de/index.xml" type="application/rss+xml" title="Big Data in Biomedicine">
  <link rel="feed" href="https://biomedical-big-data.de/index.xml" type="application/rss+xml" title="Big Data in Biomedicine">
  

  <link rel="manifest" href="/site.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="https://biomedical-big-data.de/publication/sippl-2019/">

  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="og:site_name" content="Big Data in Biomedicine">
  <meta property="og:url" content="https://biomedical-big-data.de/publication/sippl-2019/">
  <meta property="og:title" content="miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme | Big Data in Biomedicine">
  <meta property="og:description" content="*Background*&lt;br/&gt;Glioblastoma multiforme is the most frequent malignant brain tumor in adults being marked with a very poor prognosis. Therapy concept implies concomitant radio-chemotherapy and facultative implantation of carmustine-eluted wafer. Current literature suggests microRNA 26a expression in glioblastoma to interact with alkylating chemotherapy. Subsequently, the aim of this study was to investigate the correlation of miRNA-26a expression and carmustine wafer implantation and its potential usefulness as a predictive marker for therapy response.&lt;br/&gt;&lt;br/&gt;*Methods*&lt;br/&gt;In total, 229 patients with glioblastoma multiforme were included into the final analysis. Of them, 80 cases were recruited from the Saarland University Medical Center for a retrospective matched-pair analysis stratified after therapy regime: One group (carmustine wafer group; n=40) received concomitant radio-chemotherapy with carmustine wafer implantation. The other group (control group; n=40) only received concomitant radio-chemotherapy. The results were confirmed by comparing them with an independent dataset of 149 patients from the TCGA database. All tumor specimens were evaluated for miRNA-26a expression, MGMT promoter methylation, and IDH1 R132H mutation status, and the results were correlated with the clinical data.&lt;br/&gt;&lt;br/&gt;*Results*&lt;br/&gt;Twenty-three patients in the carmustine wafer group showed low expression of miRNA-26a, while 17 patients showed a high expression. In the control group, 28 patients showed low expression, while 12 patients showed a high expression. The patients with high miRNA-26a expression in the carmustine wafer group were characterized by a significantly longer overall (hazard ratio [HR] 2.750 [95% CI 1.352–5.593]; p=0.004) and progression-free survival (HR 3.091 [95% CI 1.436–6.657]; p=0.003) than patients with low miRNA-26a expression. The 17 patients in the carmustine wafer group with high miRNA-26a expression showed a significantly longer progression-free survival (p=0.013) and overall survival (p=0.007) compared with the control group. There were no such correlations identified within the control group. TCGA datasets supported these findings.&lt;br/&gt;&lt;br/&gt;*Conclusions*&lt;br/&gt;MiRNA-26a expression turned out to be a promising predictor of therapy response and clinical outcome in glioblastoma patients treated with carmustine wafer implantation. For evaluation of the role of miRNA-26a in a combined therapy setting, further studies are needed in order to translate general findings to the patient’s individual situation.">
  
  
    
  <meta property="og:image" content="https://biomedical-big-data.de/img/biomedbigdata_logo_square.png">
  <meta property="og:locale" content="en-us">
  
  <meta property="article:published_time" content="2019-01-01T00:00:00&#43;01:00">
  
  <meta property="article:modified_time" content="2019-01-01T00:00:00&#43;01:00">
  

  

  

  <title>miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme | Big Data in Biomedicine</title>

</head>
<body id="top" data-spy="scroll" data-target="#TableOfContents" data-offset="71" class="dark">
  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header fixed-top">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/"><img src="/img/biomedbigdata_logo.png" alt="Big Data in Biomedicine"></a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav ml-auto">
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#about">
            
            <span>Home</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#posts">
            
            <span>Posts</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#talks">
            
            <span>Talks</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#publications_selected">
            
            <span>Publications</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
            
          
        

        <li class="nav-item">
          <a class="nav-link" href="https://exbio.de/list-lab/" target="_blank" rel="noopener">
            
            <span>Group</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#projects">
            
            <span>Projects</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#teaching">
            
            <span>Teaching</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#contact">
            
            <span>Contact</span>
            
          </a>
        </li>

        
        

      

        

        

        
      </ul>

    </div>
  </div>
</nav>

<div class="pub" itemscope itemtype="http://schema.org/CreativeWork">

  












  

  
  
  
<div class="article-container pt-3">
  <h1 itemprop="name">miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme</h1>

  

  
    

<div class="article-metadata">

  
  
  
  <div>
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Christoph Sippl</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Ralf Ketter</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Luisa Braun</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Fritz Teping</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Louisa Schoeneberger</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Yoo Jin Kim</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Markus List</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Arjang Nakhoda</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Silke Wemmert</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">Joachim Oertel</span>
    </span>, 
    <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">others</span>
    </span>
    
  </div>
  

  <span class="article-date">
    
    <meta content="2019-01-01 00:00:00 &#43;0100 CET" itemprop="datePublished">
    <time datetime="2019-01-01 00:00:00 &#43;0100 CET" itemprop="dateModified">
      01. Jan 2019
    </time>
  </span>
  <span itemscope itemprop="publisher" itemtype="http://schema.org/Person">
    <meta itemprop="name" content="Markus List">
  </span>

  

  
  

  

  
  
<div class="share-box" aria-hidden="true">
  <ul class="share">
    <li>
      <a class="twitter"
         href="https://twitter.com/intent/tweet?text=miRNA-26a%20expression%20influences%20the%20therapy%20response%20to%20carmustine%20wafer%20implantation%20in%20patients%20with%20glioblastoma%20multiforme&amp;url=https%3a%2f%2fbiomedical-big-data.de%2fpublication%2fsippl-2019%2f"
         target="_blank" rel="noopener">
        <i class="fab fa-twitter"></i>
      </a>
    </li>
    <li>
      <a class="facebook"
         href="https://www.facebook.com/sharer.php?u=https%3a%2f%2fbiomedical-big-data.de%2fpublication%2fsippl-2019%2f"
         target="_blank" rel="noopener">
        <i class="fab fa-facebook-f"></i>
      </a>
    </li>
    <li>
      <a class="linkedin"
         href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https%3a%2f%2fbiomedical-big-data.de%2fpublication%2fsippl-2019%2f&amp;title=miRNA-26a%20expression%20influences%20the%20therapy%20response%20to%20carmustine%20wafer%20implantation%20in%20patients%20with%20glioblastoma%20multiforme"
         target="_blank" rel="noopener">
        <i class="fab fa-linkedin-in"></i>
      </a>
    </li>
    <li>
      <a class="weibo"
         href="http://service.weibo.com/share/share.php?url=https%3a%2f%2fbiomedical-big-data.de%2fpublication%2fsippl-2019%2f&amp;title=miRNA-26a%20expression%20influences%20the%20therapy%20response%20to%20carmustine%20wafer%20implantation%20in%20patients%20with%20glioblastoma%20multiforme"
         target="_blank" rel="noopener">
        <i class="fab fa-weibo"></i>
      </a>
    </li>
    <li>
      <a class="email"
         href="mailto:?subject=miRNA-26a%20expression%20influences%20the%20therapy%20response%20to%20carmustine%20wafer%20implantation%20in%20patients%20with%20glioblastoma%20multiforme&amp;body=https%3a%2f%2fbiomedical-big-data.de%2fpublication%2fsippl-2019%2f">
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  </ul>
</div>


  

</div>

    







  






  



<div class="btn-links mb-3">
  
  






  



  
    
  


<a class="btn btn-outline-primary my-1 mr-1" href="https://link.springer.com/article/10.1007/s00701-019-04051-8" target="_blank" rel="noopener">
  PDF
</a>



<button type="button" class="btn btn-outline-primary my-1 mr-1 js-cite-modal"
        data-filename="/publication/sippl-2019/sippl-2019.bib">
  Cite
</button>













<a class="btn btn-outline-primary my-1 mr-1" href="https://doi.org/10.1007/s00701-019-04051-8" target="_blank" rel="noopener">
  DOI
</a>



</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract" itemprop="text"><em>Background</em><br/>Glioblastoma multiforme is the most frequent malignant brain tumor in adults being marked with a very poor prognosis. Therapy concept implies concomitant radio-chemotherapy and facultative implantation of carmustine-eluted wafer. Current literature suggests microRNA 26a expression in glioblastoma to interact with alkylating chemotherapy. Subsequently, the aim of this study was to investigate the correlation of miRNA-26a expression and carmustine wafer implantation and its potential usefulness as a predictive marker for therapy response.<br/><br/><em>Methods</em><br/>In total, 229 patients with glioblastoma multiforme were included into the final analysis. Of them, 80 cases were recruited from the Saarland University Medical Center for a retrospective matched-pair analysis stratified after therapy regime: One group (carmustine wafer group; n=40) received concomitant radio-chemotherapy with carmustine wafer implantation. The other group (control group; n=40) only received concomitant radio-chemotherapy. The results were confirmed by comparing them with an independent dataset of 149 patients from the TCGA database. All tumor specimens were evaluated for miRNA-26a expression, MGMT promoter methylation, and IDH1 R132H mutation status, and the results were correlated with the clinical data.<br/><br/><em>Results</em><br/>Twenty-three patients in the carmustine wafer group showed low expression of miRNA-26a, while 17 patients showed a high expression. In the control group, 28 patients showed low expression, while 12 patients showed a high expression. The patients with high miRNA-26a expression in the carmustine wafer group were characterized by a significantly longer overall (hazard ratio [HR] 2.750 [95% CI 1.352–5.593]; p=0.004) and progression-free survival (HR 3.091 [95% CI 1.436–6.657]; p=0.003) than patients with low miRNA-26a expression. The 17 patients in the carmustine wafer group with high miRNA-26a expression showed a significantly longer progression-free survival (p=0.013) and overall survival (p=0.007) compared with the control group. There were no such correlations identified within the control group. TCGA datasets supported these findings.<br/><br/><em>Conclusions</em><br/>MiRNA-26a expression turned out to be a promising predictor of therapy response and clinical outcome in glioblastoma patients treated with carmustine wafer implantation. For evaluation of the role of miRNA-26a in a combined therapy setting, further studies are needed in order to translate general findings to the patient’s individual situation.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            
            <a href="/publication/#2">
              Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>Acta neurochirurgica</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Date</div>
          <div class="col-12 col-md-9" itemprop="datePublished">
            January, 2019
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-sm-none space-below"></div>

    <div class="space-below"></div>

    <div class="article-style"></div>

    

    



  







  </div>
</div>



<div class="container">
  <footer class="site-footer">
  

  <p class="powered-by">
    &copy; 2018 &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" id="back_to_top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

</div>


<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

    

    
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js" integrity="sha512-+NqPlbbtM1QqiK8ZAo4Yrj2c4lNQoGv8P79DPtKzj++l5jnN39rHA/xsqn8zE9l0uSoxaCdrOgFs6yjyfbBxSg==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.3/imagesloaded.pkgd.min.js" integrity="sha512-umsR78NN0D23AzgoZ11K7raBD+R6hqKojyBZs1w8WvYlsI+QuKRGBx3LFCwhatzBunCjDuJpDHwxD13sLMbpRA==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha256-VsEqElsCHSGmnmHXGQzvoWjWwoznFSZc6hs7ARLRacQ=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.4/isotope.pkgd.min.js" integrity="sha512-VDBOIlDbuC4VWxGJNmuFRQ0Li0SKkDpmGyuhAG5LTDLd/dJ/S0WMVxriR2Y+CyPL5gzjpN4f/6iqWVBJlht0tQ==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js" integrity="sha256-/BfiIkHlHoVihZdc6TFuj7MmJ0TWcWsMXkeDFwhi0zw=" crossorigin="anonymous"></script>
        
      

      
      
    

    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.js" integrity="sha512-lInM/apFSqyy1o6s89K4iQUKg6ppXEgsVxT35HbzUupEVRh2Eu9Wdl4tHj7dZO0s1uvplcYGmt3498TtHq+log==" crossorigin="anonymous"></script>
    

    
    
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    
    
    <script>
      const search_index_filename = "/index.json";
      const i18n = {
        'placeholder': "Search...",
        'results': "results found",
        'no_results': "No results found"
      };
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    

    

    
    

    
    

    
    
    
    
    
    
    
    
    <script src="/js/academic.min.74b0d3361475b08c40cf31120e82937b.js"></script>

    

  </body>
</html>

